Vexim SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Edison Investment Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Vexim SA announces results of study of SpineJack
Vexim SA:Says the results of a new comparative biomechanical study carried out by Marburg University’s Traumatology Department (Germany) have been published in THE SPINE JOURNAL.Says the aim of this new study was to evaluate the anatomic restoration of 24 fractured vertebral bodies with osteoporosis by comparing the SpineJack and balloon kyphoplasty techniques.Says the results once again demonstrated a difference in favor of the SpineJack regarding the restoration of vertebral height that is achieved to reestablish spinal balance.
Latest Developments forVexim SA
- Vexim reports excellent 1 yr results of comparative randomized study of Spinejack versus Balloon Kyphoplasty
- Vexim SA gives FY 2015 profit guidance
- Vexim SA obtains CE approval to market MasterflowTM Injection system in Europe
- Vexim SA announces a long term performances of SpineJack supported by 24-month follow-up clinical study
- Share this
- Digg this